Clinical Trial Update: xPedite: A Study to Expedite DIPG and DMG Research

View source ↗

Summary

The sponsor xCures reports a clinical trial called xPedite to expedite DIPG and DMG research. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma

Snippet

Sponsor: xCures | Conditions: Oncology, DIPG | Status: RECRUITING